DEXCOM, INC. Travel and Entertainment Expense
DEXCOM, INC. (DXCM) reported Travel and Entertainment Expense of $17.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:TravelAndEntertainmentExpense · last filed 2026-07-30
- DEXCOM, INC. travel and entertainment expense for the quarter ending 2026-06-30 was $17.70M, a 23.78% increase year-over-year.
- DEXCOM, INC. travel and entertainment expense for the quarter ending 2026-03-31 was $21.50M, a 9.69% increase year-over-year.
- DEXCOM, INC. travel and entertainment expense for the quarter ending 2025-12-31 was $15.30M, a 15.91% increase year-over-year.
- DEXCOM, INC. travel and entertainment expense for the quarter ending 2025-09-30 was $15.20M, a 4.83% increase year-over-year.
- DEXCOM, INC. travel and entertainment expense for fiscal 2025 was $64.40M, a 0.62% decline from fiscal 2024.
- DEXCOM, INC. travel and entertainment expense for fiscal 2024 was $64.80M, a 17.18% increase from fiscal 2023.
- DEXCOM, INC. travel and entertainment expense for fiscal 2023 was $55.30M, a 47.07% increase from fiscal 2022.
- DEXCOM, INC. travel and entertainment expense for fiscal 2022 was $37.60M.
| Period end | Travel and Entertainment Expense 3 month | Travel and Entertainment Expense 6 month | Travel and Entertainment Expense 9 month | Travel and Entertainment Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $17.70M 10-Q · filed 2026-07-30 | $39.20M 10-Q · filed 2026-07-30 | $54.50M derived: sum of 3 quarters · filed 2026-07-30 | $69.70M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $21.50M 10-Q · filed 2026-04-30 | $36.80M derived: sum of 2 quarters · filed 2026-04-30 | $52.00M derived: sum of 3 quarters · filed 2026-04-30 | $66.30M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $15.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $30.50M derived: sum of 2 quarters · filed 2026-02-12 | $44.80M derived: sum of 3 quarters · filed 2026-07-30 | $64.40M 10-K · filed 2026-02-12 |
| 2025-09-30 | $15.20M 10-Q · filed 2025-10-30 | $29.50M derived: sum of 2 quarters · filed 2026-07-30 | $49.10M 10-Q · filed 2025-10-30 | $62.30M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $14.30M 10-Q · filed 2026-07-30 | $33.90M 10-Q · filed 2026-07-30 | $47.10M derived: sum of 3 quarters · filed 2026-07-30 | $61.60M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $19.60M 10-Q · filed 2026-04-30 | $32.80M derived: sum of 2 quarters · filed 2026-04-30 | $47.30M derived: sum of 3 quarters · filed 2026-04-30 | $63.40M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $13.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $27.70M derived: sum of 2 quarters · filed 2026-02-12 | $43.80M derived: sum of 3 quarters · filed 2026-02-12 | $64.80M 10-K · filed 2026-02-12 |
| 2024-09-30 | $14.50M 10-Q · filed 2025-10-30 | $30.60M derived: sum of 2 quarters · filed 2025-10-30 | $51.60M 10-Q · filed 2025-10-30 | |
| 2024-06-30 | $16.10M 10-Q · filed 2025-07-30 | $37.10M 10-Q · filed 2025-07-30 | ||
| 2024-03-31 | $21.00M 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | $55.30M 10-K · filed 2026-02-12 | |||
| 2022-12-31 | $37.60M 10-K · filed 2025-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |